• August 03, 2020

New Cannabinoid Drug For Brain Tumor symptoms Treatment

Cannabinoid drug for Brain Tumor symptoms Treatment Prolongs the Life of Patients

Over the past few years research has unveil that marijuana can both destroy certain Brain tumor cells and reduce the growth of others. Now, a new study in mice has found that when integrated with radiation treatment cannabis can effectively halt one of the most aggressive types of brain tumors.In a paper published Friday in the journal Molecular Cancer Therapies a team of researchers from St.George’s University of London outlined the “dramatic reductions” they observed in high-grade glioma masses, a deadly form of brain cancer, Brain Tumor symptoms Treatment with a combination of radiation and two different marijuana compounds, also known as cannabinoids.

GW Pharmaceuticals announced Phase II results for a cannabinoid drug combination with the potential to increase life expectancy in patients with an aggressive form of brain cancer.GW Pharmaceuticals, one of the coolest biotechs in Cambridge, is developing cannabinoid drugs.

Its lead candidate, Epidiolex, could reach the market soon and help Brain Tumor symptoms Treatment drug-resistant forms of epilepsy in children Now, the company is presenting promising results from a Phase II trials for a cannabinoid combination for glioblastoma treatment multiforme (GBM), an aggressive form of brain tumor.A combination of tetrahydrocannabinol (THC) and cannabidiol (CBD) was used to treat 21 patients undergoing chemotherapy. This Brain Tumor symptoms Treatment  improved their one-year survival rate from 53% to 83% and extending the median survival for over 6 months when compared to a placebo.

The British company intends the drug combinations as an add-on therapy for patients Best Brain Tumor Treatment with dose-intensive temozolomide. The cannabinoid compounds had shown synergistic effects with this chemotherapy drug for brain tumors in preclinical studies.Justin Gover, CEO of GW has expressed his intentions to start regulatory procedures for a pivotal trial tofurther develop the treatment. He also mentioned that the company will be looking to expand its research into additional forms of cancer.GW Pharmaceuticals has done extensive research on the effects of cannabinoids in brain tumor growth and progression in multiple forms of cancer. From lung to breast, pancreatic, melanoma ovarian, gastric, renal, prostate and bladder cancer.GW’s Sativex (nabiximols) was the first cannabis-derived drug to ever be approved, and the company has few competitors given the polemic behind these compounds. If the company is successful in cancer Treatment with cannabinoid drugs, maybe they could end up gaining wider recognition for their therapeutic properties.

About the Author